CIK 0001689375
- Accelerated filer
- Smaller reporting company
- Emerging growth company
Entrada Therapeutics, Inc.
Sign in to watch- Ticker
- TRDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813983399
- Phone
- +1 857-305-1825
- Business address
- ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, MA, 02210
- Former names
- CycloPorters, Inc.
- 4 Open-market sale Chief Financial Officer sold 600 shares at an average $13.02 ($7,814)
- 4 Open-market sale President and CEO sold 2,000 shares at $12.00 ($24,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Operating Officer sold 7,714 shares at $13.00 ($100,282)
- 4 Open-market sale President and CEO sold 4,000 shares at $12.00 ($48,000)
- 4 Open-market buy 10% owner bought 40,947 shares at an average $6.37 ($260,760)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 48,509 shares at an average $5.82 ($282,447)
- 4 Open-market buy 10% owner bought 71,944 shares at an average $5.99 ($430,701)
- 4 Grant or award Chief Operating Officer acquired 11,263 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 11,588 shares (grant or award)
Page 10 of 13 · 242 filings